InformationVenue Auditorium Barcelona School Management. U. Pompeu Fabra Balmes, 132-134. 08008 Barcelona. Spain

Information and Abstractswww.neuropsychiatry-hiv.com

Registration - Deadline: May 11th, 2017 Standard: 500 € (21% VAT not included).Psychologist or student: 250 € (21% VAT not included).

Include: Participation at the scientific sessions, official Symposium printed materials, coffee and lunch breaks.

Registration and Payment:a) Online: Fill in the online form.Payment by credit card is automatically processed.If payment is by bank transfer, the payment code you willreceive by e-mail must appear.

b) By e-mail:Download the form, fill in it and send it along the copy of the bank transfer to info@neuropsychiatry-hiv.comImportant: Indicate in the concept of the transfer the name of the attendee.

Data for the bank transfer: Owner: C & C - Symposium Neuropsychiatry & HIV.Bank: Caixabank, S.A. IBAN account: ES6721003447712200082884. SWIFT: CAIXESBBXXX

th

InternationalSymposium on Neuropsychiatry & HIV

Technical SecretariatC&C, Congresos y ConvencionesContact Person: Ruth BozaRonda Guinardó, 2708024-Barcelona (Spain) Tel: +34 934173113info@neuropsychiatry-hiv.com

Practical focus on the diagnosis and treatment of the psychiatric andneuropsychological aspects ofHIV-infected patients.

Barcelona May 18-19, 2018www.neuropsychiatry-hiv.com

Activity accredited by the Consell Català de Formació Continuada de les Professions Sanitàries and the Comisión de Formación Continuada del Sistema Nacional de Salud from Spain.

Accreditations 11

Sponsorship

0,9 Credits

Saturday, May 19th

09:00-09:45 amSymposium 4. Cost-effective comprehensive mental health care for people with HIV.Moderators: Guida da Ponte – David J. GrelottiMilton Wainberg.

09:45-10:30 amSymposium 5 Neurotoxicity of antiretrovirals.Moderators: Alejandro Arenas Pinto – Claudia CinqueAndrea Calcagno.

10:30-11:15 amCoffee Break & Poster Session 2

11:15-12:30 pmOral Communications. Session 2Moderators: Annemiek Schadé – Andrea Calcagno 2.1 Correlates of Cerebral White Matter Hyperintensities in HIV-positive Patients. Giacomo Stroffolini. 2.2 Potential Benefits for the Brain as a Result of the Use of Kick&Kill Strategies: The Other Side of the Coin?. José A. Muñoz-Moreno 2.3 The Prevalence of Cerebrospinal Fluid HIV Escape Varie According to Different Definitions and Underlying Comorbidities. Ilaria De Benedetto. 2.4 Impact of HIV severity on neurocognitive profile in perinatally HIV-infected young adults. Cristina García-Navarro. 2.5 Compensatory brain activity in well controlled vertical HIV young adults. Carlos Velo 2.6 Antineuronal antibodies and neuropsychiatric symptoms in

ProgrammeFriday, May 18th

08:30-09:00 amDelivery of documentation.

09:00-09:15 am Opening.

09:15-10:00 am Symposium 1. How to manage sleep disturbances in HIV. Moderators: Jordi Blanch - Esteban Martínez Joan Santamaria.

10:00-10:45 amSymposium 2. Cannabis use and HIV. Moderators: Scott Letendre-Jose A. Muñoz MorenoDavid J. Grelotti.

10:45:11:30 amCoffee Break & Poster Session 1

11:30-11:50 amForward thinking – managing CNS disorders in HIV. Moderators: Jordi Blanch - Esteban Martínez Glenn Treisman

11:50-01:00 pmOral Communications. Session 1Moderators: José A. Muñoz Moreno – Milton Wainberg

1.1 HCV coinfection as a risk-marker of non-adherence to ART. Carlos Parro Torres 1.2 Who Will Be Lost? A Psychosocial Review on Loss to Follow-Up in People with HIV. Pere Torres-Bertral 1.3 The role of attention in antiretroviral therapy adherence. Daniel Hernández-Huerta 1.4 “Erantsi” A guide for therapeutic support to HIV positive persons living with other associated morbidities. Carmen Vicioso 1.5 Dolutegravir induced neurotoxicity Beatriz Maria Sanjuan 1.6 Descriptive study of admitted patients with HIV infection in an Acute Psychiatric Unit. Antonio Soudo Ventura.

01:00-02:00 pmLunchtime

02:00-02:45 pmSymposium 3. Psychotropic medications, Recreational drugs

Organization

Scientific sponsorship

AIDS Spanish National Planand Antiretrovirals.Moderators: Ignacio Pérez-Valero – Alan Winston Catia Marzolini.

Friday, May 18th

02:45-05:30 pmWorkshops. (Session without simultaneous translation)1. Neurocognitive impairment: - Scope of the problem. Gabriele Arendt. - Screening. Ignacio Perez-Valero. - Diagnosis. Alejandro Arenas-Pinto. - Prevention. Paola Cinque. - Treatment. Alan Winston.

2. Neuropsychiatric disorders in HIV: - Scope of the problem. Milton Wainberg - Screening of Neurocognitive Diorders. Jose Muñoz-Moreno. - Diagnosis. Annemiek Shadé. - Treatment. Guida Da Ponte.Presentation of 15 min. for each topic and 15 minutes of discussion with questions about screening, diagnostic, prevention and treatment.

VIH infection. Susana Arboleya

Saturday, May 19th

12:30-01:30 pmSymposium 6. Hot topics on CNS and HIV.Moderators: Jordi Blanch-Esteban Martínez. Scott Letendre.

01:30-01:45 pmClosure and Farewell

Scientific Committee Alejandro Arenas-Pinto, MBBS, MSc, PhD. University College London. United Kingdom.Gabriel Arendt, MD. University Hospital of Düsseldorf, Germany Andrea Calcagno, MD. University of Torino, Italy Paola Cinque, MD. Hospital San Rafael. Milan, ItalyGuida Da Ponte, MD. Centro Hospitalar Barreiro-Montijo. Portugal.David J. Grelotti, MD. University of California. San Diego, USA. Scott Letendre, MD. University of California. San Diego, USACatia Marzolini, MD. University Hospital of Basel, Switzerland.José A. Muñoz-Moreno, PhD. Lluita contra la SIDA Foundation. Barcelona, Spain.Ignacio Pérez-Valero, MD. Hospital Universitario La Paz. Madrid, Spain.Joan Santamaria, MD. Hospital Universitari Clinic. Barcelona, Spain.Annemiek Schadé, MD. Univ. Hospital VU. Amsterdam. Netherlands. Milton Wainberg, MD. Columbia University. New York, USAAlan Winston, MD. St. Mary’s Hospital. London, United Kingdom.

CoordinatorsEsteban Martínez, MD.Infectious Diseases Unit. Hospital Clinic. Barcelona. Spain.

Jordi Blanch, MD.Psychiatry Unit. Hospital Clínic. Barcelona. Spain.